UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Arterial lesions in giant cell arteritis: A longitudinal study

Seminars in arthritis and rheumatism, 2019-02, Vol.48 (4), p.707-713

2019

Volltextzugriff (PDF)

Rho Kinase Expression in Giant Cell Arteritis: Validating Phosphorylated Ezrin/Radixin/Moesin Intensity Score to Increase Sensitivity of Temporal Artery Biopsy

Journal of rheumatology, 2022-08, Vol.49 (8), p.908-912

2022

Volltextzugriff (PDF)

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Science translational medicine, 2018-01, Vol.10 (423)

2018

Volltextzugriff (PDF)

Current Therapies for ANCA-Associated Vasculitis

Annual review of medicine, 2015-01, Vol.66 (1), p.227-240

2015

Volltextzugriff (PDF)

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

Arthritis research & therapy, 2021-01, Vol.23 (1), p.8-8, Article 8

2021

Volltextzugriff (PDF)

Pulmonary Vasculitis

Rheumatic diseases clinics of North America, 2015-05, Vol.41 (2), p.315-331

2015

Volltextzugriff (PDF)

The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis

Journal of autoimmunity, 2019-12, Vol.105, p.102302-102302, Article 102302

2019

Volltextzugriff (PDF)

COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study

Seminars in arthritis and rheumatism, 2024-08, Vol.67, p.152453, Article 152453

2024

Volltextzugriff (PDF)

Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Is There Still a Role for Cyclophosphamide?

Rheumatic diseases clinics of North America, 2019-08, Vol.45 (3), p.379-398

2019

Volltextzugriff (PDF)

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Arthritis research & therapy, 2015-08, Vol.17 (1), p.213, Article 213

2015

Volltextzugriff (PDF)

Current Landscape of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Rheumatic diseases clinics of North America, 2015-02, Vol.41 (1), p.1-19

2015

Volltextzugriff (PDF)

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

Arthritis research & therapy, 2023-10, Vol.25 (1), p.1-199, Article 199

2023

Volltextzugriff (PDF)

Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study

Journal of rheumatology, 2019-12, Vol.46 (12), p.1605-1613

2019

Volltextzugriff (PDF)

Advances in the treatment of polymyalgia rheumatica and giant cell arteritis

Nature reviews. Rheumatology, 2024-02, Vol.20 (2), p.77-78

2024

Volltextzugriff (PDF)

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis

Analytical chemistry (Washington), 2016-06, Vol.88 (12), p.6317-6325

2016

Volltextzugriff (PDF)

Effectiveness of Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis (Wegener's)

Arthritis care & research (2010), 2014-09, Vol.66 (9), p.1403-1409

2014

Volltextzugriff (PDF)

Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment

Journal of rheumatology, 2017-05, Vol.44 (5), p.631-638

2017

Volltextzugriff (PDF)

Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis

Annals of internal medicine, 2007-11, Vol.147 (9), p.611

2007

Volltextzugriff (PDF)

Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study

The Lancet. Rheumatology, 2022-04, Vol.4 (4), p.e243-e246

2022

Volltextzugriff (PDF)

Biomarkers in ANCA-Associated Vasculitis

Current rheumatology reports, 2013-10, Vol.15 (10), p.363-363, Article 363

2013

Volltextzugriff (PDF)

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis

Arthritis research & therapy, 2016-01, Vol.18 (27), p.27-27, Article 27

2016

Volltextzugriff (PDF)

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis

Current opinion in rheumatology, 2010-11, Vol.22 (6), p.690-695

2010

Volltextzugriff (PDF)

B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab

Journal of rheumatology, 2023-03, Vol.50 (3), p.420

2023

Volltextzugriff (PDF)

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis

Current opinion in rheumatology, 2010-11, Vol.22 (6), p.690-695

2010

Volltextzugriff (PDF)

Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis

Journal of autoimmunity, 2015-05, Vol.59, p.43-52

2015

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

KollektionFree E-Journal (出版社公開部分のみ）

ThemaWegener's Granulomatosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(68)
Buchkapitel
(2)

Sprache

Englisch
(70)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(48)
Humans
(40)
Rheumatology
(34)
Female
(21)
Male
(20)
Middle Aged
(20)
Adult
(14)
Aged
(14)
Scleroderma
(12)
Systemic Sclerosis
(12)
Giant Cell Arteritis
(7)
Immunosuppressive Agents - Therapeutic Use
(7)
Rituximab
(7)
Treatment Outcome
(7)
Anca-Associated Vasculitis
(6)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Drug Therapy
(6)
Biological And Medical Sciences
(6)
General & Internal Medicine
(6)
Medicine, General & Internal
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Arterial lesions in giant cell arteritis: A longitudinal study

Rho Kinase Expression in Giant Cell Arteritis: Validating Phosphorylated Ezrin/Radixin/Moesin Intensity Score to Increase Sensitivity of Temporal Artery Biopsy

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Current Therapies for ANCA-Associated Vasculitis

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

Pulmonary Vasculitis

The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis

COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study

Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Is There Still a Role for Cyclophosphamide?

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Current Landscape of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study

Advances in the treatment of polymyalgia rheumatica and giant cell arteritis

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis

Effectiveness of Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis (Wegener's)

Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment

Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis

Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study

Biomarkers in ANCA-Associated Vasculitis

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis

B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis

Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis

Aktive Filter

Suchergebnisse filtern